Author

C. Gonzalez-Fernandez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:dimensionality reduction· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. Chamorro· 1 shared A. Dariush· 1 shared A. Fatemi· 1 shared A. Flor· 1 shared A. Küpcü Yoldas· 1 shared A. Lepore· 1 shared A. Roth· 1 shared B. Bodenmiller· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chamorro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Imaging and Molecular Annotation of Xenografts and Tumours (IMAXT) High Throughput Data and Analysis Infrastructure

E. A. Gonzalez-Solares, A. Dariush, C. Gonzalez-Fernandez, A. Küpcü Yoldas, M. Al Sa'd, N. Millar, T. Whitmarsh, N. Chornay, I. Falciatori, A. Fatemi, D. Goodwin, L. Kuett, C. M. Mulvey, M. Paez Ribes, F. Qosaj, , N. A. Walton

The paper presents an infrastructure for high-throughput data and analysis of tumour and xenograft samples using multimodal imaging and molecular annotation.

bioRxiv · Jun 22, 2021Cancer Biology

Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals.

B. Trinite, E. Pradenas, S. Marfil, C. Rovirosa, V. Urrea, F. Tarres-Freixas, R. Ortiz, J. Vergara-Alert, J. Segales, V. Guallar, A. Lepore, N. Izquierdo-Useros, G. Trujillo, J. Trape, C. Gonzalez-Fernandez, , J. Blanco

The paper assesses how prior SARS-CoV-2 infection affects B.1.1.7 cross-neutralization in vaccinated individuals, finding that previously infected individuals show equivalent neutralization against B.1.1.7 compared to the Wuhan strain.

bioRxiv · Mar 5, 2021Immunology